HPHA.DE · HEIDELBERG PHARMA AG O.N.
Germany · RS rating 13 · As of 2026-10-14
| Price | 2.20 EUR |
|---|---|
| 1-day change | -2.2% |
| RS rating (overall / 1M / 3M / 12M) | 13 / 10 / 26 / 18 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 34 / 12 / 52 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | +122.2% |
| Sales growth Q/Q | +43.3% |
| Distance from 52-week high | +32.3% |
| Market cap (USD) | $116.6M |